Veterinary Medicine Market Size, Share & Trends Analysis Report By Product (Biologics, Pharmaceuticals), By Animal, By Route of Administration, By Distribution Channel, By Region, and Segment Forecasts, 2025 - 2033

Veterinary Medicine Market Summary

The global veterinary medicine market size was estimated at USD 47.70 billion in 2024 and is projected to reach USD 113.48 billion by 2033, growing at a CAGR of 10.36% from 2025 to 2033. The market is propelling due to rising livestock population and increasing pet ownership rates, increasing number of zoonotic & chronic diseases, rising R&D and procedural advancements and increasing consumption of meat and mandatory vaccination.

Global livestock populations and companion-animal ownership are expanding rapidly, driving demand for veterinary medicine. According to the USDFDA report published in October 2025, in the U.S., cattle and calves total accounted for approximately 94.2 million, whereas India’s livestock population reached over 535 million in 2019, with significant increases in sheep, goats, and dairy animals. This growth supports herd health management, reproductive monitoring, and preventive care. Similarly, pet ownership is surging worldwide; in the U.S., 71% of households own pets, with an estimated 471 million dogs and 373 million cats globally. Thus, this rising herd and pet numbers increase veterinary visits, preventive treatments, diagnostics, and wellness spending, fueling sustained growth in the veterinary medicine market across companion and production animals.

In addition, rising prevalence of zoonotic and chronic diseases is boosting veterinary pharmaceutical and vaccine demand. Outbreaks of avian influenza, foot-and-mouth disease, and antimicrobial-resistant infections threaten livestock production, human health, and trade, highlighting the need for preventive interventions. Besides this, according to the October 2025 article by Hepper, companion animals are being affected by chronic conditions such as obesity, diabetes, kidney disease, and osteoarthritis, with up to 63% of cats and 30% of dogs overweight or obese. Hence, pet owners’ growing concern over health outcomes is driving higher expenditure on treatment, management, and preventive care. Thus, veterinary medicine adoption is accelerating globally, with vaccines, anti-infectives, and therapeutic solutions becoming critical for livestock and companion-animal health.

Furthermore, rising global meat consumption is increasing demand for livestock production and animal health interventions. The annual meat intake exceeds 350 million tons around the globe, with growth driven by Asia, Africa, and Latin America, particularly China. Expanding herds and flocks require effective disease prevention, prompting higher usage of vaccines, anti-infectives, and recombinant biological products. Many countries mandate routine vaccination of cattle and poultry to prevent foodborne illnesses. In addition, rising meat demand, coupled with antibiotic-free production trends, strengthens the need for animal health solutions that maintain herd productivity and biosecurity.

Moreover, innovation in veterinary medicine, including advanced vaccines, biologics, and therapeutics, is driving market growth. Collaborative initiatives such as the Innovative Medicines Initiative (IMI) in Europe and MediLabSecure for emerging pathogens support research and development across multiple countries. Besides this, adoption of veterinary health information systems improves communication and facilitates innovation. Companies continue launching novel products, including MSD Animal Health’s NUMELVI for atopic dermatitis in dogs, Virbac’s Vikaly medicated cat feed for kidney disease, and ZyVet’s FDA-approved generics for urinary incontinence and heart failure. These R&D advances expand treatment options, improve clinical outcomes, and encourage broader adoption of innovative pharmaceuticals and biologics in veterinary practices globally.

Global Veterinary Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary medicine market report based on product, animal, route of administration, distribution channel and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
• Vaccines
• Modified/ Attenuated Live
• Inactivated (Killed)
• Other Vaccines
• Other Biologics
• Pharmaceuticals
• Parasiticides
• Anti-infectives
• Anti-inflammatory
• Analgesics
• Others
• Medicated Feed Additives
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Production Animals
• Poultry
• Pigs
• Cattle
• Sheep & Goats
• Others
• Companion Animals
• Dogs
• Cats
• Horses
• Others
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Injectable
• Topical
• Other Routes
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• UAE
• Saudi Arabia
• Kuwait
• Qatar
• Oman

Please note The report will be delivered in 2-3 business days upon order notification. Show more